NCT Number: NCT01169688
Preoperative Cataract Pupillary Dilation: Inpatient At The Ambulatory Surgery Center vs Outpatient Dilation Prior To Arrival At The Ambulatory Surgery Center
This study was done to compare efficacy, safety and efficiencies of various methods of pupil dilation prior to cataract surgery.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Ability to self administer eye or have a helper for the task of administering eye drops.
- Ability to follow and eye drop administration schedule.
- No noted ocular abnormalities.
- Bilateral cataract surgery anticipated.
Exclusion criteria
- Inability to self administer eye drops or have assistance with eye drop administration.
- Health problems that would contraindicate self administration of dilating eye drops such as poor cardiovascular or respiratory status.
Treatment and study plan
Sponsors and collaborators
Lead sponsor
Northwest Kansas Surgery Center
Other
Registry information
Official study title
Preoperative Cataract Pupillary Dilation: Inpatient vs Outpatient
Important dates
- Study start
- 2007
- Primary completion
- 2008
- Study completion
- 2008
- First posted
- Jul 26, 2010
- Registry last updated
- Jul 26, 2010
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Pharmacodynamics of a Fixed Dose Combination of 0.34% Tropicamide and 2.5% Phenylephrine Hydrochloride, Eye Drop, Solution
NCT07075224
Eye Diseases, Mydriasis
Athens, Greece
View Trial DetailsComparison of 4 Methods of Eye Drops for Pupil Dilation in Diabetic Patients
NCT07495670
Cardiovascular Diseases, Diabetes (DM)
Chon Buri, Thailand
View Trial DetailsComfort Level in Premature Infants Undergoing Retinopathy of Prematurity Screening
NCT07016984
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Sariyer, İ̇stanbul, Turkey (Türkiye)
View Trial DetailsEfficacy and Safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening
NCT05043077
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Thessaloniki, Greece
View Trial Details